Moertel CG - Search Results

1

A pharmacologic and toxicological study of amygdalin.

Moertel CG, Ames MM, Kovach JS, Moyer TP, Rubin JR, Tinker JH. Moertel CG, et al. JAMA. 1981 Feb 13;245(6):591-4. JAMA. 1981. PMID: 7005480 Clinical Trial.

2

Pharmacology of amygdalin (laetrile) in cancer patients.

Ames MM, Moyer TP, Kovach JS, Moertel CG, Rubin J. Ames MM, et al. Among authors: moertel cg. Cancer Chemother Pharmacol. 1981;6(1):51-7. doi: 10.1007/BF00253010. Cancer Chemother Pharmacol. 1981. PMID: 7273266

3

A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin.

Cullinan SA, Moertel CG, Fleming TR, Rubin JR, Krook JE, Everson LK, Windschitl HE, Twito DI, Marschke RF, Foley JF, et al. Cullinan SA, et al. Among authors: moertel cg. JAMA. 1985 Apr 12;253(14):2061-7. JAMA. 1985. PMID: 2579257 Clinical Trial.

4

Phase I study of two schedules of teroxirone.

Rubin J, Kovach JS, Ames MM, Moertel CG, Creagan ET, O'Connell MJ. Rubin J, et al. Among authors: moertel cg. Cancer Treat Rep. 1987 May;71(5):489-92. Cancer Treat Rep. 1987. PMID: 3567975

5

High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison.

Moertel CG, Fleming TR, Creagan ET, Rubin J, O'Connell MJ, Ames MM. Moertel CG, et al. N Engl J Med. 1985 Jan 17;312(3):137-41. doi: 10.1056/NEJM198501173120301. N Engl J Med. 1985. PMID: 3880867 Clinical Trial.

6

A clinical trial of amygdalin (Laetrile) in the treatment of human cancer.

Moertel CG, Fleming TR, Rubin J, Kvols LK, Sarna G, Koch R, Currie VE, Young CW, Jones SE, Davignon JP. Moertel CG, et al. N Engl J Med. 1982 Jan 28;306(4):201-6. doi: 10.1056/NEJM198201283060403. N Engl J Med. 1982. PMID: 7033783 Clinical Trial.

7

Phase I and pharmacokinetic studies of DON.

Kovach JS, Eagan RT, Powis G, Rubin J, Creagan ET, Moertel CG. Kovach JS, et al. Among authors: moertel cg. Cancer Treat Rep. 1981 Nov-Dec;65(11-12):1031-6. Cancer Treat Rep. 1981. PMID: 7296548

8

Phase I and clinical pharmacological evaluation of a parenteral hexamethylmelamine formulation.

Ames MM, Richardson RL, Kovach JS, Moertel CG, O'Connell MJ. Ames MM, et al. Among authors: moertel cg. Cancer Res. 1990 Jan 1;50(1):206-10. Cancer Res. 1990. PMID: 2104537 Clinical Trial.

9

Phase I study of N-(phosphonacetyl)-L-aspartic acid (PALA).

Kovach JS, Schutt AJ, Moertel CG, O'Connell MJ. Kovach JS, et al. Among authors: moertel cg. Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1909-12. Cancer Treat Rep. 1979. PMID: 526923

10

Phase I study of hycanthone.

Kovach JS, Moertel CG, Schutt AJ, Eagan RT. Kovach JS, et al. Among authors: moertel cg. Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1965-9. Cancer Treat Rep. 1979. PMID: 526930

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

314 results

Search Page